Next Article in Journal
Identification of 16S rRNA and Virulence-Associated Genes of Arcobacter in Water Samples in the Kathmandu Valley, Nepal
Next Article in Special Issue
In Vitro Activity of Statins against Naegleria fowleri
Previous Article in Journal
Erratum: Man, A., et al. Antimicrobial Activity of Six Essential Oils Against a Group of Human Pathogens: A Comparative Study. Pathogens 2019, 8, 15
Previous Article in Special Issue
Serological and Molecular Findings of Leishmania Infection in Healthy Donkeys (Equus asinus) from a Canine Leishmaniosis Endemic Focus in Tuscany, Italy: A Preliminary Report
Article

In Vitro Evaluation of Combined Commercialized Ophthalmic Solutions Against Acanthamoeba Strains

1
Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna. Av. Astrofísico Francisco Sánchez S/N, 38203 Tenerife, España
2
Departamento de Ciencias Agronómicas y Veterinarias, Instituto Tecnológico de Sonora, Cd. Obregón, Sonora 95370, Mexico
3
Departmento de Oftalmología, Hospital Universitario de Canarias, 38320 La Laguna, Tenerife, Canary Islands, Spain
4
Laboratoire Matériaux-Molécules et Applications, La Marsa, University of Carthage, Tunisia 1003, Tunisia
*
Author to whom correspondence should be addressed.
Pathogens 2019, 8(3), 109; https://doi.org/10.3390/pathogens8030109
Received: 11 July 2019 / Revised: 22 July 2019 / Accepted: 24 July 2019 / Published: 25 July 2019
(This article belongs to the Special Issue Emerging Parasitic Protozoa)
Acanthamoeba is a free-living amoebae genus which is present worldwide in natural and artificial environments. These amoebae are clinically important as causative agents of diseases in humans and other animals such as a fatal encephalitis or a sight threatening Acanthamoeba keratitis (AK). Lately; studies have focused on the search of novel therapeutic options for AK but also to prevent infections. Furthermore; the evaluation of commercialized products seems to be an option for this case since not clinical assays would be required. Thus; we aimed to test the amoebicidal activity of different mixtures of two commercial ophthalmic solutions: Systane® Ultra; which has already shown anti-Acanthamoeba properties; and Naviblef® Daily Care. In addition, we tested their cytotoxic effect against murine macrophages. At the individual level; Naviblef® Daily Care showed to be the most active product against Acanthamoeba spp. Nevertheless; the combinations of Systane® Ultra and Naviblef® Daily Care; showed an improvement in the activity against trophozoites and cysts of Acanthamoeba castellanii Neff. Moreover; the concentration necessary to generate cytotoxic effect against murine macrophages (J774.1) was much higher than the required for the amoebicidal and cysticidal effect achieved in the most effective mixtures. View Full-Text
Keywords: Acanthamoeba; keratitis; ophthalmic solution; chemotherapy; amoebicidal activity Acanthamoeba; keratitis; ophthalmic solution; chemotherapy; amoebicidal activity
Show Figures

Figure 1

MDPI and ACS Style

Reyes-Batlle, M.; Mura-Escorche, G.; Sifaoui, I.; Otero-Ruiz, A.; Alfaro-Sifuentes, R.; López-Arencibia, A.; Rocha-Cabrera, P.; Chiboub, O.; Rizo-Liendo, A.; Zamora-Herrera, J.; Bethencourt-Estrella, C.J.; Rodríguez-Expósito, R.L.; San Nicolás-Hernández, D.; Piñero, J.E.; Lorenzo-Morales, J. In Vitro Evaluation of Combined Commercialized Ophthalmic Solutions Against Acanthamoeba Strains. Pathogens 2019, 8, 109. https://doi.org/10.3390/pathogens8030109

AMA Style

Reyes-Batlle M, Mura-Escorche G, Sifaoui I, Otero-Ruiz A, Alfaro-Sifuentes R, López-Arencibia A, Rocha-Cabrera P, Chiboub O, Rizo-Liendo A, Zamora-Herrera J, Bethencourt-Estrella CJ, Rodríguez-Expósito RL, San Nicolás-Hernández D, Piñero JE, Lorenzo-Morales J. In Vitro Evaluation of Combined Commercialized Ophthalmic Solutions Against Acanthamoeba Strains. Pathogens. 2019; 8(3):109. https://doi.org/10.3390/pathogens8030109

Chicago/Turabian Style

Reyes-Batlle, María, Glorian Mura-Escorche, Ines Sifaoui, Alejandro Otero-Ruiz, Rosalía Alfaro-Sifuentes, Atteneri López-Arencibia, Pedro Rocha-Cabrera, Olfa Chiboub, Aitor Rizo-Liendo, Jonadab Zamora-Herrera, Carlos J. Bethencourt-Estrella, Rubén L. Rodríguez-Expósito, Desirée San Nicolás-Hernández, José E. Piñero, and Jacob Lorenzo-Morales. 2019. "In Vitro Evaluation of Combined Commercialized Ophthalmic Solutions Against Acanthamoeba Strains" Pathogens 8, no. 3: 109. https://doi.org/10.3390/pathogens8030109

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop